Cyp2d6 metabolizer phenotype predicts aripiprazole pharmacokinetics in children and adolescents
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY(2023)
摘要
The objectives of this presentation are to evaluate the impact of the cytochrome P450 enzyme, 2D6 (CYP2D6) phenotype on aripiprazole and dehydroaripiprazole pharmacokinetics in youth.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要